MyAverix Finance
F · Healthcare
Duality Biotherapeutics, Inc. (4ZB)
Biotechnology
Duality Biotherapeutics, Inc. (4ZB) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4ZB
Duality Biotherapeutics, Inc. (4ZB) — FAQ
What is 4ZB's P/E ratio?
The price-to-earnings (P/E) ratio for Duality Biotherapeutics, Inc. (4ZB) is 25.00 (data as of 2026-05-23).
Does Duality Biotherapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Duality Biotherapeutics, Inc. (4ZB). Check the MyAverix Finance app for the latest dividend data.
What sector is Duality Biotherapeutics, Inc. in?
Duality Biotherapeutics, Inc. (4ZB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 4ZB listed on?
4ZB is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.